Suchergebnisse - "Baricitinib"

PubPharm (1.395)

21

Alopecia areata treatment with baricitinib : different relapse phenotypes

enthalten in: The Journal of dermatological treatment | 2024

von Dall'Oglio, F. | Nasca, M. | Lacarrubba, F. | +2

22

Long-term efficacy and safety of baricitinib in patients with severe alopecia areata : 104-week results from BRAVE-AA1 and BRAVE-AA2

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Senna, M. | Mostaghimi, A. | Ohyama, M. | +8

23

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19 : A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

enthalten in: Annals of internal medicine | 2024

von Paules, C. | Wang, J. | Tomashek, K. | +18

24

Baricitinib for refractory Takayasu arteritis : a prospective cohort study in a tertiary referral centre

enthalten in: RMD open | 2024

von Zhou, Z. | Fang, C. | Wang, L. | +6

25

Successful treatment of alopecia areata-associated trachyonychia with baricitinib

enthalten in: International journal of dermatology | 2024

von Rózsa, P. | Degovics, D. | Baltás, E. | +2

26

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

enthalten in: Dermatology and therapy | 2024

von Gargiulo, L. | Ibba, L. | Malagoli, P. | +11

27

Coassembly Nanomedicine Mediated by Intermolecular Interactions Between Methotrexate and Baricitinib for Improved Rheumatoid Arthritis Treatment

enthalten in: ACS nano | 2024

von Xiong, H. | Zhang, H. | Qin, Y. | +9

28

IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα

enthalten in: International journal of molecular sciences | 2024

von Recchia Luciani, G. | Barilli, A. | Visigalli, R. | +3

29

Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Wollenberg, A. | Simon, D. | Kulthanan, K. | +7

30

Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa : A retrospective case series

enthalten in: The Journal of dermatology | 2024

von Kwon, I. | Kim, S. | Kim, S. | +1